VTR Stock Summary and Trading Ideas (Ventas | NYSE:VTR)

Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.

Ventas trades on the NYSE stock market under the symbol VTR.

As of October 30, 2026, VTR stock price climbed to $84.80 with 4,773,209 million shares trading.

VTR has a beta of -0.16, meaning it tends to be less sensitive to market movements. VTR has a correlation of 0.01 to the broad based SPY ETF.

VTR has a market cap of $44.84 billion. This is considered a Large Cap stock.

Last quarter Ventas reported $2 billion in Revenue and $.99 earnings per share. This beat revenue expectation by $56 million and exceeded earnings estimates by $.01.

In the last 3 years, VTR traded as high as $101.60 and as low as $40.98.

The top ETF exchange traded funds that VTR belongs to (by Net Assets): VNQ, VTI, VOO, VO, IVV.

VTR has outperformed the market in the last year with a price return of +24.4% while the SPY ETF gained +11.0%. However, in the short term, VTR had mixed performance relative to the market. It has underperformed in the last 3 months, returning -12.7% vs +3.9% return in SPY. But in the last 2 weeks, VTR shares have fared better than the market returning -0.1% compared to SPY -2.1%.

VTR support price is $82.33 and resistance is $85.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VTR shares will trade within this expected range on the day.